In an interview with Consultant360, Kasia Rothenberg, MD, PhD, a geriatric psychiatrist at the Cleveland Clinic Lou Ruvo Center for Brain Health, described the challenges caregivers or family members face...
In an interview with Consultant360, Paul B. Rosenberg, MD, discussed his team’s research on using dronabinol, a legal form of synthetic THC, to treat agitation in patients with Alzheimer disease. What...
In a 2024 review, the International Psychogeriatric Association introduces a systematic method to manage agitation in patients with Alzheimer disease. Take our quiz to test your knowledge on this...
A new study found transcranial pulse stimulation treatment may improve behavioral symptoms such as aggression or agitation in patients with Alzheimer disease. Take our quiz to test your knowledge on its...
In a recent interview with Consultant360, Kasia Rothenberg, MD, PhD, a geriatric psychiatrist at the Cleveland Clinic Lou Ruvo Center for Brain Health, described the many obstacles to accurate testing. Do...
In their presentation at the Practical Updates in Primary Care 2023 Virtual Series, Craig Chepke, MD, DFAPA, and Kevin Williams, MS, MPAS, PA-C reviewed the pathophysiological mechanisms of agitation...
A cluster randomized controlled trial found that a certain intervention reduced agitation in nursing home residents with Alzheimer disease or related dementia compared with those treated with usual care....
A new study found transcranial pulse stimulation treatment may improve behavioral symptoms such as aggression or agitation in patients with Alzheimer disease. Take our quiz to test your knowledge on its...
